X-LINKED RETINOSCHISIS
Clinical trials for X-LINKED RETINOSCHISIS explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINOSCHISIS trials appear
Sign up with your email to follow new studies for X-LINKED RETINOSCHISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental gene therapy aims to restore sight in rare childhood blindness
Disease control Recruiting nowThis study tests a new gene therapy called ATSN-201 for people with X-linked retinoschisis, a rare genetic eye disease that causes vision loss. The trial includes children and adults aged 6 and older, and will check if the treatment is safe and can improve vision. The therapy wor…
Matched conditions: X-LINKED RETINOSCHISIS
Phase: PHASE3 • Sponsor: Atsena Therapeutics Inc. • Aim: Disease control
Last updated May 02, 2026 06:04 UTC
-
New study aims to sharpen vision tests for those with severe sight loss
Knowledge-focused Recruiting nowThis study is for people with retinal diseases like retinitis pigmentosa and Stargardt disease who have severe vision loss (20/200 to hand motion). Researchers want to see if standard vision tests work well for these patients and how reliable they are. The goal is to develop bett…
Matched conditions: X-LINKED RETINOSCHISIS
Sponsor: Ray Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 02, 2026 06:04 UTC